相关实验视频

Updated: May 27, 2025

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

通过深度突变扫描对MET受体氨酸激酶的基因酶域抵抗机制进行映射

Gabriella O Estevam^1,2, Edmond Linossi^3,4, Jingyou Rao⁵

¹Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, United States.

|February 17, 2025

概括

这项研究对11种抑制剂的MET激酶域突变进行了分析,以确定耐药性和敏感性模式. 通过预测MET驱动癌症的有效治疗方法,研究结果有助于精准医学.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
药理学药理学是指药理学的学科.

背景情况:

在MET受体氨酸激酶突变驱动癌症和治疗耐药性.
个性化医学需要将抑制剂与特定的MET突变配置文件相匹配.

研究的目的:

对MET抑制剂的MET激酶域变异进行全面分析.
为了确定各种MET抑制剂的耐药性和敏感性突变.
改进MET向治疗的预测模型.

主要方法:

对~5764个MET激酶域变体进行深度突变扫描.
测试对11种MET激酶域抑制剂的突变生长.
增强蛋白质语言模型的生物物理和化学特征.

主要成果:

已知验证的MET抑制剂耐药性突变.
在不同类型的抑制剂 (I,II,I 1⁄2) 中确定了常见的耐药部位.
发现了针对单个抑制剂的独特耐药性和敏感性突变.
对I型和II型抑制剂组合的经过验证的非交叉耐药性敏感性.
改进了蛋白质语言模型,用于预测抑制剂有效性.

结论:

开发了一个聚合的实验管道,用于识别MET抑制剂耐药性突变.
创建了一个对特定MET向治疗敏感突变的参考词典.
为开发下一代MET抑制剂和个性化癌症治疗提供了洞察力.

关键词:

生物化学生物化学化学生物学化学生物学发现药物的发现.人类人类人类人类人类人类人类突变发生的突变发生.蛋白质激酶酶是一种蛋白质激酶.

更多相关视频

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

相关概念视频

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Receptor Tyrosine Kinases

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...